RecruitingPhase 4NCT05435547

Preoperative Corticosteroids in Autoimmune Thyroid Disease

Randomized Controlled Trial of Preoperative Corticosteroids in Autoimmune ThyroidDisease

Sponsor

Indiana University

Enrollment

76 participants

Start Date

Jun 16, 2023

Study Type

INTERVENTIONAL

Conditions

Graves Disease Hashimoto Disease

Summary

This study proposes to randomize patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of corticosteroids decreases the inflammation of the gland and makes surgery less difficult.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone and a drug called Placebo for people with graves disease and hashimoto disease. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone

Will take Dexamethasone pre-operatively

DRUGPlacebo

Will take Placebo pre-operatively

Locations(3)

IU Health North Hospital

Indianapolis, Indiana, United States

IU Health Methodist Hospital

Indianapolis, Indiana, United States

IU Health University Hospital

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05435547

Related Trials

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

NCT0757031618 locations

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

NCT075968497 locations

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

NCT0766105621 locations

Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease

NCT060814391 location

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

NCT07722546